EyeMirage Device for Visual Function
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device, EyeMirage, to compare its effectiveness with standard eye tests. It measures visual acuity (clarity of vision), visual field (the area visible), color vision, and eye movements. The trial includes individuals with vision of 20/200 or better who are willing to try both the new and standard tests. Those with severe vision loss or certain neurological conditions are not eligible. As an unphased trial, participants contribute to innovative research that may enhance future eye care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the EyeMirage device is safe for eye function testing?
Research has shown that the EyeMirage device assesses various aspects of eye function, such as visual acuity, visual field, color vision, and self-paced saccades. The device has been compared to standard tests conducted in eye clinics.
No reports of problems or safety issues have emerged from these comparisons. This trial focuses on evaluating the effectiveness of the EyeMirage device, not on testing a new drug or surgical treatment, which typically involves fewer safety concerns. Participants will have a follow-up to discuss any issues, but current evidence suggests the device is safe to use.12345Why are researchers excited about this trial?
Researchers are excited about the EyeMirage device because it offers a new way to assess vision by integrating technology with traditional methods. Unlike standard tests that are often separate and manual, EyeMirage combines visual acuity, visual field, color vision, and saccade assessments into one streamlined digital process using both a device and an app. This method promises to be faster and potentially more convenient for both patients and healthcare providers, while also delivering comprehensive results. By comparing EyeMirage directly with standard care, researchers aim to find out if this innovative approach can enhance the accuracy and efficiency of visual function assessments.
What evidence suggests that the EyeMirage device is effective for eye function testing?
Research has shown that the EyeMirage device holds promise for testing eye functions such as visual clarity, peripheral vision, color vision, and eye movement speed. In this trial, one group of participants will first undergo assessments using standard tests, followed by the EyeMirage device, while another group will use the EyeMirage device first, followed by standard tests. Early studies found that EyeMirage produces results similar to standard eye clinic tests. This suggests the device might be as reliable as traditional methods. EyeMirage could offer accurate and effective eye health assessments, making it a potential tool for eye exams.23567
Who Is on the Research Team?
Bram Ramjiawan, PhD
Principal Investigator
St. Boniface Hospital Asper Clinical Research Institute
Are You a Good Fit for This Trial?
This clinical trial is for individuals aged 18 to 65 who are undergoing standard eye examinations. Participants will be assessed using both the EyeMirage device and standard devices during a single clinic visit, with a follow-up call after thirty days.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo four eye tests using both the new EyeMirage device and the standard of care devices
Follow-up
Participants are monitored for any issues and discuss results 30 days after the eye tests
What Are the Treatments Tested in This Trial?
Interventions
- EyeMirage
Find a Clinic Near You
Who Is Running the Clinical Trial?
Neuroptek Corporation Inc.
Lead Sponsor
St. Boniface Hospital
Collaborator
St. Boniface Hospital Asper Clinical Research Institute
Collaborator